abstract |
The object of the present invention is to provide drugs and / or methods for preventing, slowing, delaying or treating metabolic disorders, particularly type 2 diabetes. The present invention relates to an antidiabetic agent suitable for the treatment or prevention of one or more conditions selected from type 1 diabetes, type 2 diabetes, impaired glucose tolerance and hyperglycemia, among others. In addition, the invention relates to methods for preventing or treating metabolic disorders and related conditions. The drug therapy is a monotherapy using a DPP-4 inhibitor (preferably linagliptin) or a combination therapy using a DPP-4 inhibitor and a second and / or third antidiabetic agent. [Selection figure] None |